Untitled

Abstract

Lymphatic Filariasis (LF) is a major public health problem not only in India but also other developed countries. Filariasis is the disease which is caused by a group of filarial worms. It is transmitted by mosquitoes -Culex quinquefasciatus globally the most important vector. They cause high morbidity and mortality among humans. The proper management is needed for preventing the morbidity and mortality by laboratory diagnostic methods. Irreversible "elephantiasis" is the major clinical manifestation for LF. Diethylcarbamazine (DEC) is the drug of choice for treating lymphatic filariasis. Sequential gradient pump therapy and complete decongestive therapy (CDT) are some additional treatment for better therapeutic value.